MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations

American Journal of Dermatopathology

Volumn 35, Issue 1, 2013, Pages 25-29

  Nybakken, Grant E ^a   Sargen, Michael ^a   Abraham, Ronnie ^a   Zhang, Paul J ^a   Ming, Michael ^b   Xu, Xiaowei ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Atypical intraepidermal melanocytic proliferation; Immunohistochemistry; Melan A; Melanoma in situ; Microphthalmia Associated transcription factor; S100

Indexed keywords

EOSIN; HEMATOXYLIN; MELAN A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN S 100;

ADOLESCENT; ADULT; AGED; ARTICLE; ATYPICAL INTRAEPIDERMAL MELANOCYTIC PROLIFERATION; BASEMENT MEMBRANE; CARCINOMA IN SITU; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTE; MELANOMA IN SITU; PRIORITY JOURNAL; SKIN DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MART-1 ANTIGEN; MELANOCYTES; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; S100 PROTEINS; SKIN NEOPLASMS; STAINING AND LABELING; YOUNG ADULT;

EID: 84873408690     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31825666c3     Document Type: Article

References (17)

1. Prieto VG, Shea CR. Use of immunohistochemistry in melanocytic lesions. J Cutan Pathol. 2008;35(suppl 2):1-10.
2. Orchard GE. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma. Histochem J. 2000;32:475-481.
3. Cross SS, Hamdy FC, Deloulme JC, et al. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology. 2005;46:256-269.
4. Stefansson K, Wollmann R, Jerkovic M. S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes. Am J Pathol. 1982;106:261-268.
5. Argenyi ZB, Cain C, Bromley C, et al. S-100 protein-negative malignant melanoma: Fact or fiction? A light-microscopic and immunohistochemical study. Am J Dermatopathol. 1994;16:233-240.
6. Dorvault CC, Weilbaecher KN, Yee H, et al. Microphthalmia transcription factor: A sensitive and specific marker for malignant melanoma in cytologic specimens. Cancer. 2001;93:337-343.
7. Busam KJ, Chen YT, Old LJ, et al. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol. 1998;22:976-982.
8. El Shabrawi-Caelen L, Kerl H, Cerroni L. Melan-A: Not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. Am J Dermatopathol. 2004;26:364-366.
9. Maize JC Jr, Resneck JS Jr, Shapiro PE, et al. Ducking stray "magic bullets": A Melan-A alert. Am J Dermatopathol. 2003;25:162-165.
10. Beltraminelli H, Shabrawi-Caelen LE, Kerl H, et al. Melan-A-positive "pseudomelanocytic nests": A pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damaged skin. Am J Dermatopathol. 2009;31:305-308.
11. Smoller BR. Histologic criteria for diagnosing primary cutaneous malignant melanoma. Mod Pathol. 2006;19(suppl 2):S34-S40.
12. Elder DE, Murphy GF; and Armed Forces Institute of Pathology (U.S.); Universities Associated for Research and Education in Pathology. Melanocytic Tumors of the Skin. Washington, DC: Armed Forces Institute of Pathology: Available from the American Registry of Pathology; 2010.
13. Kim J, Taube JM, McCalmont TH, et al. Quantitative comparison of MiTF, Melan-A, HMB-45 and Mel-5 in solar lentigines and melanoma in situ. J Cutan Pathol. 2011;38:775-779.
14. King R, Googe PB, Weilbaecher KN, et al. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol. 2001;25:51-57.
15. Garraway LA, Widlund HR, Rubin MA, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005;436:117-122.
16. Brochez L, Verhaeghe E, Grosshans E, et al. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol. 2002;196:459-466.
17. Wilson ML, Hossler EW, Ferringer TC, et al. S100-negative junctional melanocytic proliferations. Am J Dermatopathol. 2011;33:327-329.